1. Home
  2. SHIM vs NERV Comparison

SHIM vs NERV Comparison

Compare SHIM & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shimmick Corporation

SHIM

Shimmick Corporation

BUY

Current Price

$2.34

Market Cap

128.6M

Sector

N/A

ML Signal

BUY

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$2.30

Market Cap

166.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHIM
NERV
Founded
1990
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
128.6M
166.4M
IPO Year
2023
2014

Fundamental Metrics

Financial Performance
Metric
SHIM
NERV
Price
$2.34
$2.30
Analyst Decision
Strong Buy
Buy
Analyst Count
2
3
Target Price
$7.00
★ $10.33
AVG Volume (30 Days)
95.3K
★ 105.4K
Earning Date
11-12-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 81.95
N/A
EPS
★ N/A
N/A
Revenue
★ $492,844,000.00
$41,175,600.00
Revenue This Year
$1.41
N/A
Revenue Next Year
$20.36
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 2.63
N/A
52 Week Low
$1.95
$2.24
52 Week High
$6.76
$8.80

Technical Indicators

Market Signals
Indicator
SHIM
NERV
Relative Strength Index (RSI) 27.89 27.35
Support Level N/A N/A
Resistance Level $4.09 $5.69
Average True Range (ATR) 0.18 0.26
MACD -0.03 -0.02
Stochastic Oscillator 15.03 4.83

Price Performance

Historical Comparison
SHIM
NERV

About SHIM Shimmick Corporation

Shimmick Corp is engaged in delivering turnkey infrastructure solutions that strengthen critical markets across water, energy, climate resiliency, and sustainable transportation. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains critical infrastructure, including mass transit, bridges, and military infrastructure. The company has one operating and reportable segment: infrastructure solutions. All of its revenue is derived from the United States.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: